1 / 17

ANTINEOPLASTIC AGENTS

LECTURE 9 B. ANTINEOPLASTIC AGENTS. PHARMACOLOGY. OBJECTIVE. To cause a lethal lesion that can arrest tumor’s progression. The attack is generally against the metabolic sites that are essential for cell replication. Ideally, only malignant cells should be targeted.

calix
Télécharger la présentation

ANTINEOPLASTIC AGENTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. LECTURE 9 B ANTINEOPLASTIC AGENTS PHARMACOLOGY

  2. OBJECTIVE • To cause a lethal lesion that can arrest tumor’s progression. • The attack is generally against the metabolic sites that are essential for cell replication. • Ideally, only malignant cells should be targeted. • However, currently no such drugs are available that specifically recognize neoplastic cells, resulting in the appearance of adverse drug reactions (ADRs).

  3. CLASSIFICATION • Antimetabolites • Antibiotics • Alkylating agents • Microtubule inhibtors • Steroids • Others

  4. ANTIMETABOLITES • Methotrexate, mercaptpurine • Act at S phase of the cell cycle • They inhibit the synthesis of nucleotides by altering various genetic mechanisms • Used in leukemia, lymphoma, inflammatory diseases. • ADRs: Neurological, renal, hepatic, pulmonary, resistance.

  5. METHOTREXATE MOA

  6. Mercaptopurine MOA

  7. ANTIBIOTICS • Dactinomycin , Bleomycin, Daunorubicin, Doxorubicin • Interaction with DNA, leading to disruption of DNA function • Usually in combination with other anticancer agents • Choriocarcinoma, Breast, lung, leukemia, lymphoma • ADRs: Same as for antimetabolites plus skin reactions and immunosuppression

  8. ALKYLATING AGENTS • Cyclophophamide, nitrosoureas (carmustine) • Covalently binding to nucleophilic groups on the DNA. Resulting in the disruption of cell growth • Used in lymphomas, leukemias and solid tumors • Same as above plus nausea, latent viral infections (why?), alopecia, neutropenia.

  9. MICROTUBULE INHIBITORS • Vincristine, vinblastine, paclitaxel • Act on the spindle fibers to halt cell division • The most commonly used anticancer agents. • Lekemia, lymphoma, soft and hard tissue tumors. • ADRs: Same as above plus neuropathy (ataxia, foot drop)

  10. STEROIDS • Prednisone, tamoxifen, estrogens • Only good for hormone responsive tumors • Breast, ovarian, prostatic (plus sometimes in addition to other agents for decreasing inflammation) • ADRs: Same as above

  11. OTHERS • Cisplatin – similar to alkylating agents • Carbaplatin - similar to alkylating agents • Etoposide – irreversible DSBs (double stranded breaks) • Interferons – active against tumor cells by initiating immune response against them.

  12. THANK YOU

More Related